SCHEMBL4928815

SCHEMBL4928815

O=C(/C=C/c1ccc(CN(CCCN2CCOCC2)C(=O)NC(=O)c2ccccc2)cc1)NO

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 8/20 0.51
▸ HDAC8 Q9BY41 6/20 0.50
▸ HDAC3 O15379 3/20 0.47
▸ HDAC4 P56524 3/20 0.47
▸ HDAC7 Q8WUI4 3/20 0.47
▸ HDAC2 Q92769 3/20 0.47
▸ HDAC10 Q969S8 3/20 0.47
▸ HDAC11 Q96DB2 3/20 0.47
▸ HDAC6 Q9UBN7 3/20 0.47
▸ HDAC9 Q9UKV0 3/20 0.47
▸ HDAC5 Q9UQL6 3/20 0.47
▸ NAMPT P43490 5/20 0.46
▸ TSHR P16473 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ ALDH1A1 P00352 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ LMNA P02545 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4928819 1.00 HDAC1 (0.51) HDAC1HDAC8HDAC3HDAC4HDAC7
SCHEMBL4928807 0.95 HDAC1 (0.49) HDAC1HDAC8HDAC3HDAC4HDAC7
SCHEMBL4928802 0.95 HDAC1 (0.49) HDAC1HDAC8HDAC3HDAC4HDAC7
SCHEMBL4931918 0.92 HDAC1 (0.53) HDAC1HDAC8HDAC3HDAC4HDAC7
SCHEMBL4931926 0.92 HDAC1 (0.53) HDAC1HDAC8HDAC3HDAC4HDAC7
SCHEMBL4926649 0.90 HDAC1 (0.52) HDAC1HDAC8HDAC3HDAC4HDAC7
SCHEMBL4926667 0.90 HDAC1 (0.52) HDAC1HDAC8HDAC3HDAC4HDAC7
SCHEMBL4928592 0.86 HDAC1 (0.48) HDAC1HDAC8HDAC3HDAC4HDAC7
SCHEMBL4928606 0.86 HDAC1 (0.48) HDAC1HDAC8HDAC3HDAC4HDAC7
SCHEMBL4928765 0.85 HDAC1 (0.47) HDAC1HDAC8HDAC3HDAC4HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080070954-A1 Acylurea Connected And Sulfonylurea Connected Hydroxamates S*BIO PTE LTD. (SG) 2008-03-20 — — US disclosed
US-20080070954-A1 Acylurea Connected And Sulfonylurea Connected Hydroxamates S*BIO PTE LTD. (SG) 2008-03-20 — — US disclosed
US-20080070954-A1 Acylurea Connected And Sulfonylurea Connected Hydroxamates S*BIO PTE LTD. (SG) 2008-03-20 — — US disclosed
WO-2005040101-A1 ACYLUREA CONNECTED AND SULFONYLUREA CONNECTED HYDROXAMATES S*BIO PTE LTD (SG) 2005-05-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080070954-A1 Acylurea Connected And Sulfonylurea Connected Hydroxamates HDAC1, HDAC3, HDAC4 HDAC1 1/4885HDAC8 7/4885HDAC3 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback